Is VRTX up or down today?
VRTX is down 4.05% today, last at 530.76. This stock moved -4.05% versus the prior close.
VRTX · Vertex Pharmaceuticals
VRTX (Vertex Pharmaceuticals) is trading at 530.76, down 4.05% on the session. VRTX sits at the 77% mark of its 52-week range, carries a 14-day RSI of 53, and trades above its 50-day average. Over the past month it is up 5.41%.
Leading the coverage: “Vertex Pharmaceuticals (VRTX) Stock Rethinks Q3 Results After Profit Squeeze - Simply Wall St” (Google News Earnings, 5h ago).
VRTX trades on a trailing P/E of 31.9 and is running 7.40% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
VRTX is down 4.05% today, last at 530.76. This stock moved -4.05% versus the prior close.
Leading the coverage: “Vertex Pharmaceuticals (VRTX) Stock Rethinks Q3 Results After Profit Squeeze - Simply Wall St” (Google News Earnings, 5h ago). Dominant story: Vertex Pharmaceuticals (VRTX) Stock Rethinks Q3 Results After Profit Squeeze - Simply Wall St (3 sources, bullish) RSI is 53 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Vertex Pharmaceuticals (VRTX) Stock Rethinks Q3 Results After Profit Squeeze - Simply Wall St
Vertex Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $592.56, Implies 7% Upside - TradingView
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.61% on Nov 3: Drivers Behind the Movement - TradingKey
VRTX Maintained by JP Morgan -- Price Target Raised to $570 - GuruFocus
VRTX Maintains Buy Rating -- Price Target Raised to $725 - GuruFocus